Figure 3From: FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapyKaplan-Meier analysis of survival rates according to the standardized uptake value obtained before therapy (SUV1). Patients with SUV1 ≥14.2 worse lower local recurrence–free survival (A), distant metastasis–free survival (B), progression-free survival (C), and overall survival (D) relative to those with SUV1 <14.2.Back to article page